Study of the Combination of Panobinostat and Carfilzomib in Patients With Relapsed/Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Carfilzomib
Related studies linked through entity extraction aliases.
Carfilzomib, Rituximab and Dexamethasone in Waldenstrom's Macroglobulinemia
- Status
- COMPLETED
- Phase
- PHASE2
A Safety and Efficacy Study of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Carfilzomib Multiple Myeloma Expanded Access Protocol for Patients With Relapsed and Refractory Disease
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Carfilzomib, Lenalidomide, and Dexamethasone in New Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE2
Filanesib and Carfilzomib in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Infusional Carfilzomib in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Carfilzomib in Treating Patients With Relapsed or Refractory T-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Carfilzomib vs Best Supportive Care in Subjects With Relapsed and Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Panobinostat and Carfilzomib in Treating Participants With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Trial of Carfilzomib Plus Melphalan and Prednisone in Elderly Untreated Patients With Multiple Myeloma (CARMYSAP)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Carfilzomib, Pegylated Liposomal Doxorubicin Hydrochloride, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1 Study of TG02 Citrate in Patients With Advanced Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Carfilzomib in Patients With Relapsed Acute Myeloid or Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
UARK 2009-32 Compassionate Use Study of Carfilzomib
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
A Study of Extended Carfilzomib Therapy for Patients Previously Enrolled in Carfilzomib Treatment Protocols
- Status
- COMPLETED
- Phase
- PHASE2
Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function
- Status
- COMPLETED
- Phase
- PHASE2